Literature DB >> 29158420

Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.

Ashley R Burg1, Shaonli Das1, Lindsey E Padgett1, Zachary E Koenig1, Hubert M Tse2.   

Abstract

Coxsackievirus B infections are suspected environmental triggers of type 1 diabetes (T1D) and macrophage antiviral responses may provide a link to virus-induced T1D. We previously demonstrated an important role for NADPH oxidase (NOX)-derived superoxide production during T1D pathogenesis, as NOX-deficient NOD mice (NOD.Ncf1m1J ) were protected against T1D due, in part, to impaired proinflammatory TLR signaling in NOD.Ncf1m1J macrophages. Therefore, we hypothesized that loss of NOX-derived superoxide would dampen diabetogenic antiviral macrophage responses and protect from virus-induced diabetes. Upon infection with a suspected diabetogenic virus, Coxsackievirus B3 (CB3), NOD.Ncf1m1J mice remained resistant to virus-induced autoimmune diabetes. A concomitant decrease in circulating inflammatory chemokines, blunted antiviral gene signature within the pancreas, and reduced proinflammatory M1 macrophage responses were observed. Importantly, exogenous superoxide addition to CB3-infected NOD.Ncf1m1J bone marrow-derived macrophages rescued the inflammatory antiviral M1 macrophage response, revealing reduction-oxidation-dependent mechanisms of signal transducer and activator of transcription 1 signaling and dsRNA viral sensors in macrophages. We report that superoxide production following CB3 infection may exacerbate pancreatic β cell destruction in T1D by influencing proinflammatory M1 macrophage responses, and mechanistically linking oxidative stress, inflammation, and diabetogenic virus infections.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29158420      PMCID: PMC5736405          DOI: 10.4049/jimmunol.1700478

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets.

Authors:  D V Serreze; E W Ottendorfer; T M Ellis; C J Gauntt; M A Atkinson
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

3.  Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.

Authors:  Marc S Horwitz; Alex Ilic; Cody Fine; Enrique Rodriguez; Nora Sarvetnick
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

4.  Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.

Authors:  M S Horwitz; C Fine; A Ilic; N Sarvetnick
Journal:  J Autoimmun       Date:  2001-05       Impact factor: 7.094

Review 5.  A new look at viruses in type 1 diabetes.

Authors:  Hee-Sook Jun; Ji-Won Yoon
Journal:  Diabetes Metab Res Rev       Date:  2003 Jan-Feb       Impact factor: 4.876

Review 6.  Enterovirus infections and type 1 diabetes.

Authors:  Heikki Hyöty
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

7.  NF-kappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages.

Authors:  Pradip Sen; Sandip Bhattacharyya; Mark Wallet; Carmen P Wong; Brian Poligone; Maitreyee Sen; Albert S Baldwin; Roland Tisch
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

8.  Coxsackievirus B3-resistant mice become susceptible in Se/vitamin E deficiency.

Authors:  Melinda A Beck; Deitra Williams-Toone; Orville A Levander
Journal:  Free Radic Biol Med       Date:  2003-05-15       Impact factor: 7.376

9.  Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.

Authors:  Marc S Horwitz; Alex Ilic; Cody Fine; Balaji Balasa; Nora Sarvetnick
Journal:  Clin Immunol       Date:  2004-02       Impact factor: 3.969

10.  Tissue culture of isolated human pancreatic islets infected with different strains of coxsackievirus B4: assessment of virus replication and effects on islet morphology and insulin release.

Authors:  G Frisk; H Diderholm
Journal:  Int J Exp Diabetes Res       Date:  2000
View more
  6 in total

1.  Neutrophil Cytosolic Factor 1 Contributes to the Development of Sepsis.

Authors:  Dei-Fang Chen; Xiu-Zhen Cui; Wen-Ming Cao; Wen Meng
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes.

Authors:  Rocky Strollo; Chiara Vinci; Y K Stella Man; Sara Bruzzaniti; Erica Piemonte; Ghadeer Alhamar; Silvia Irina Briganti; Ilaria Malandrucco; Flavia Tramontana; Chiara Fanali; James Garnett; Roberto Buccafusca; Perrin Guyer; Mark Mamula; Eddie A James; Paolo Pozzilli; Johnny Ludvigsson; Paul G Winyard; Mario Galgani; Ahuva Nissim
Journal:  Diabetologia       Date:  2022-10-07       Impact factor: 10.460

Review 3.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

Review 4.  Innate Viral Sensor MDA5 and Coxsackievirus Interplay in Type 1 Diabetes Development.

Authors:  Samuel I Blum; Hubert M Tse
Journal:  Microorganisms       Date:  2020-07-03

Review 5.  The Role of β Cell Stress and Neo-Epitopes in the Immunopathology of Type 1 Diabetes.

Authors:  Jon D Piganelli; Mark J Mamula; Eddie A James
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-18       Impact factor: 5.555

Review 6.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.